Drug

CuraScientific $600,000 License Purchase to Expand Delivery and Customer Acquisition

Retrieved on: 
Wednesday, May 31, 2023
Agreement, Sales, Procurement, The Purchase Price, Anxiety, Negotiation, Sale, Acquisition, OTC, Cannabis, CSTF, Drug, Real estate, License

The Company’s subsidiary, Cal Care Grp, Inc., acquired the Commercial-Microbusiness Cannabis License(s) C12-0000334 pursuant the 8K Filing of the License Purchase Agreement with Chad Enterprises, LLC, doing business as Foundation Delivery.

Key Points: 
  • The Company’s subsidiary, Cal Care Grp, Inc., acquired the Commercial-Microbusiness Cannabis License(s) C12-0000334 pursuant the 8K Filing of the License Purchase Agreement with Chad Enterprises, LLC, doing business as Foundation Delivery.
  • Both the Seller and the License(s) are active and in Good Standing in the State of California.
  • William Reed, Chairman & CEO, stated, “As a part of our core business model, we have been acquiring licensed cannabis businesses in order to expand our customer acquisition, delivery routes and territories.
  • This transaction increases our customer acquisition, distribution of our brands and expands our routes through We are negotiating with 2 more companies, Las Vegas-Nevada and Santa Ana-California.”

The Shyft Group to Attend the 20th Annual Craig-Hallum Institutional Investor Conference

Retrieved on: 
Wednesday, May 31, 2023
The Shyft Group, Conference, Cryptocurrency, Grocery store, Drug

The Shyft Group will be hosting one-on-one meetings with institutional investors throughout the day.

Key Points: 
  • The Shyft Group will be hosting one-on-one meetings with institutional investors throughout the day.
  • The Shyft Group is the North American leader in specialty vehicle manufacturing, assembly, and upfit for the commercial, retail, and service specialty vehicle markets.
  • The Shyft Group is organized into two core business units: Shyft Fleet Vehicles and Services™ and Shyft Specialty Vehicles™.
  • The Shyft Group and its go-to-market brands are well known in their respective industries for quality, durability, and first-to-market innovation.

StateHouse Reports First Quarter 2023 Financial Results

Retrieved on: 
Wednesday, May 31, 2023
Diamond, Statehouse, Partnership, CSE, Cannabis, Conference call, Bank statement, CPG, Tax, Foot, Clemson University, Sale, Genetics, Investment, Growth, Adjustment, CO2, Sunset Boulevard, Retail, Beauty salon, Video game, Mobile phone, Drug, Conference

SAN DIEGO and TORONTO, May 31, 2023 (GLOBE NEWSWIRE) -- StateHouse Holdings Inc. (“StateHouse” or the “Company”) (CSE: STHZ) (OTCQX: STHZF), a California-focused, vertically integrated cannabis enterprise, today announced its financial results for the three-month period ended March 31, 2023 (“Q1 2023”), and provided additional business updates. The unaudited condensed interim consolidated financial statements for Q1 2023, as well as the corresponding management’s discussion and analysis are available for download from the Company’s investor website, statehouseholdings.com, and on the Company’s SEDAR profile. Unless otherwise indicated, all dollar amounts in this press release are denominated in U.S. currency.

Key Points: 
  • ET
    SAN DIEGO and TORONTO, May 31, 2023 (GLOBE NEWSWIRE) -- StateHouse Holdings Inc .
  • (“StateHouse” or the “Company”) (CSE: STHZ) (OTCQX: STHZF), a California-focused, vertically integrated cannabis enterprise, today announced its financial results for the three-month period ended March 31, 2023 (“Q1 2023”), and provided additional business updates.
  • “We're off to a fantastic start in 2023,” said Ed Schmults, Chief Executive Officer of StateHouse.
  • StateHouse will host a conference call today, May 31, 2023, to discuss these results.

Cannabis Prohibition Still Plays an Outsized Role in the Evolution of the Cannabis Industry

Retrieved on: 
Wednesday, May 31, 2023
Cannabis, Impact, Education, History, Consumer, Public, Drug

The report examines trends across cannabis and how the history of cannabis prohibition continues to impact the industry as a whole.

Key Points: 
  • The report examines trends across cannabis and how the history of cannabis prohibition continues to impact the industry as a whole.
  • “Cannabis prohibition continues to have a profound impact on every face of the cannabis industry, even as more states bring legal markets online and consumption normalizes,” said Gary Allen, New Frontier Data CEO.
  • “From product preferences to social equity programs and everything in between, prohibition has shaped the cannabis narrative.
  • Cannabis Trends in 2023: Products, Consumers, and the Impact of Prohibition on the Industry contains many more details and findings on the lasting impacts of cannabis prohibition; download a complimentary copy at: https://info.newfrontierdata.com/cannabis-trends-in-2023

Omnium Canna, First Filipino-American Owned Cannabis Processor, Debuts at CWCB Expo 2023 with Three Dynamic Brands and Cannabis Accessories

Retrieved on: 
Wednesday, May 31, 2023
Cannabis, Javits Center, Congress, FC Kramatorsk, Drug

The company's strategic location ensures swift and efficient supply chain support to 80% of New York's cannabis consumers.

Key Points: 
  • The company's strategic location ensures swift and efficient supply chain support to 80% of New York's cannabis consumers.
  • "This is a momentous occasion for Omnium Canna as we strive to revolutionize the cannabis landscape," says Howard Hoffman, CEO of Omnium Canna.
  • "Our team is excited to debut three unique and innovative brands to the New York State market at the CWCB Expo."
  • For more information about Omnium Canna and its debut at the CWCB Expo, visit www.OmniumCanna.com .

EV Cargo Expands In South East Asia With New Malaysia Office

Retrieved on: 
Tuesday, May 30, 2023
EV, Atmosphere, Kuala Lumpur International Airport, E-commerce, LCL, Cargo, Johor Port, Growth, CFS, Tunnel, Transport, Drug

HONG KONG, May 30, 2023 (GLOBE NEWSWIRE) -- EV Cargo, a leading global freight forwarding, supply chain and technology company, is continuing its expansion in South East Asia with the opening of new offices and freight centres in Malaysia as part of its latest chapter of its growth strategy across Asia.

Key Points: 
  • HONG KONG, May 30, 2023 (GLOBE NEWSWIRE) -- EV Cargo, a leading global freight forwarding, supply chain and technology company, is continuing its expansion in South East Asia with the opening of new offices and freight centres in Malaysia as part of its latest chapter of its growth strategy across Asia.
  • South East Asia is a region with huge potential for EV Cargo.
  • “Malaysia offers exciting growth opportunities for EV Cargo and we’re executing quickly across South East Asia to expand our presence and build a robust EV Cargo network underpinned by professional teams,” explains Justin Bentley, EV Cargo Vice President, South East Asia.
  • “Our expanded presence and capability in Malaysia and South East Asia, underpinned by our investment in local expertise, will see EV Cargo capitalise on opportunities in the region to help deliver our wider growth strategy.”

Grön Announces Oregon Exclusive Launch of Reformulated Sugar-Coated Pearls, MEGA Pearls, Pips, & Chocolate Made With Rosin

Retrieved on: 
Tuesday, May 30, 2023
Taste, Cannabis, Pressure, Temperature, Drug

PORTLAND, Ore., May 30, 2023 (GLOBE NEWSWIRE) -- Grön (pronounced grewn), the acclaimed woman-led producer of delicious, handcrafted cannabis-infused edibles, today announced the introduction of the reformulated line of edibles available exclusively in Oregon. Grön’s beautifully delicious Sugar-Coated Pearls, MEGA Pearls, Pips, & Chocolate are now made with rosin, a solventless high-quality concentrate that delivers the fullest expression of the cannabis plant without sacrificing the taste.

Key Points: 
  • Grön’s beautifully delicious Sugar-Coated Pearls, MEGA Pearls, Pips, & Chocolate are now made with rosin, a solventless high-quality concentrate that delivers the fullest expression of the cannabis plant without sacrificing the taste.
  • The newly reformulated Grön edibles feature a superior quality rosin.
  • The hash rosin extraction process preserves all of the full-spectrum cannabinoids and beneficial plant properties, increasing their bioavailability for a more potent, full-bodied experience.
  • “We’re excited to bring the latest cannabis extraction technology to our Oregon community,” said Christine Smith, Founder and CEO of Grön.

urban-gro, Inc. Announces Upcoming Conference Participation

Retrieved on: 
Tuesday, May 30, 2023
Spindle, Business development, Education, Controlled-environment agriculture, Fire, EVP, Booth, Fire protection, Architecture, K-12, Pre-construction services, Corporation, Role, Conference, Cryptocurrency, Management, Drug, Engineering

20 th Annual Craig-Hallum Institutional Investor Conference , Minneapolis, MN, May 30-31: Bradley Nattrass, Chairman & CEO and Dan Droller, EVP of Corporate Development & Investor Relations, will be participating in one-on-one investor meetings.

Key Points: 
  • 20 th Annual Craig-Hallum Institutional Investor Conference , Minneapolis, MN, May 30-31: Bradley Nattrass, Chairman & CEO and Dan Droller, EVP of Corporate Development & Investor Relations, will be participating in one-on-one investor meetings.
  • Fire Sprinkler Contractors Texas Expo 2023 , League City, Texas, June 1: urban-gro will be exhibiting and networking at this regional event.
  • International Cannabis Business Conference , Berlin, Germany, June 29-30: urban-gro will be exhibiting at Booth 448.
  • To schedule a one-on-one meeting with management at these conferences, attendees should contact [email protected] or their conference host representative.

Axsome Therapeutics to Present Data and Post-Hoc Analyses on Auvelity® and Sunosi® at the 2023 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

Retrieved on: 
Tuesday, May 30, 2023
Presenteeism, Major depressive disorder, Central nervous system, Solriamfetol, Obstructive sleep apnea, Somnolence, State University of New York Upstate Medical University, EDS, Narcolepsy, Disability, Functional disorder, OSA, CNS, ASCP, Drug, MDD, MD, Patient, Domain, Ontario Prehospital Advanced Life Support Studies, Randomness, Medication discontinuation, Annual general meeting, Magnetic resonance, United, Therapy, SHARP, Society, Dextromethorphan/bupropion, Cognitive deficit, Pharmaceutical industry, Medical device, Apnea

NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced presentations on Auvelity® (dextromethorphan-bupropion), Sunosi® (solriamfetol), and disease state at the upcoming American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, being held from May 30-June 3 in Miami. The presentations on Auvelity incorporate new data and post-hoc analyses including demonstration of functional improvement in patients with major depressive disorder (MDD). The presentations on Sunosi include data from the SHARP (Solriamfetol’s Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled) study demonstrating improvement in cognitive function in patients with excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA).

Key Points: 
  • NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced presentations on Auvelity® (dextromethorphan-bupropion), Sunosi® (solriamfetol), and disease state at the upcoming American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, being held from May 30-June 3 in Miami.
  • The presentations on Auvelity incorporate new data and post-hoc analyses including demonstration of functional improvement in patients with major depressive disorder (MDD).
  • The presentations on Sunosi include data from the SHARP (Solriamfetol’s Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled) study demonstrating improvement in cognitive function in patients with excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA).
  • “MDD is the leading cause of disability worldwide and improvement in functioning is critically important to people with MDD.

MS Canada Joins Global Efforts on World MS Day to Foster Connection and Advance MS Research and Awareness

Retrieved on: 
Tuesday, May 30, 2023
Canada, Multiple sclerosis research, Heart, International, Senior, Mission, Research, Multiple sclerosis, MS, Organization, Community, Investment, Multiple Sclerosis International Federation, Drug

TORONTO, May 30, 2023 (GLOBE NEWSWIRE) -- MS Canada, the country’s leading organization in multiple sclerosis (MS) research and advocacy is proud to participate in World MS Day, an annual global initiative led by the MS International Federation (MSIF).

Key Points: 
  • TORONTO, May 30, 2023 (GLOBE NEWSWIRE) -- MS Canada, the country’s leading organization in multiple sclerosis (MS) research and advocacy is proud to participate in World MS Day, an annual global initiative led by the MS International Federation (MSIF).
  • With one of the highest rates of MS worldwide, MS Canada serves as a global leader and collaborator in advancing MS research, treatments, and awareness.
  • The organization works closely with international MS organizations to improve the lives of individuals affected by MS.
    World MS Day, held annually on May 30, serves to raise awareness and to unite the global MS community.
  • As a founding member of the International Progressive MS Alliance and longstanding member of the Multiple Sclerosis International Federation, MS Canada actively participates in global efforts to advance research, treatment, and well-being initiatives for MS.